ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 121 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $156,595 | -29.7% | 14,690 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $222,700 | +138.1% | 14,690 | +30.9% | 0.00% | +200.0% |
| Q1 2020 | $93,513 | -50.7% | 11,226 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $189,719 | -9.0% | 11,226 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $208,467 | -41.8% | 11,226 | -28.2% | 0.00% | -50.0% |
| Q2 2019 | $357,956 | +50.1% | 15,645 | +37.9% | 0.00% | +33.3% |
| Q1 2019 | $238,535 | +82.8% | 11,348 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $130,502 | -49.9% | 11,348 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $260,437 | +2.9% | 11,348 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $253,000 | -2.3% | 11,348 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $259,000 | -12.8% | 11,348 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $297,000 | – | 11,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
| Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
| Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
| LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
| Miura Global Management | 435,000 | $8,348,000 | 0.63% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
| Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
| BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
| Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
| FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |